New catalytic transformations are critical to advance and produce new molecular probes and therapies. We are involved in the discovery and development of new stereoselective processes that access molecules via unconventional approaches though the combination of unique activation modes. These cooperative catalysis studies will fundamentally advance human health by providing innovative tactics and strategies to access many important classes of health relevant compounds.
|Effective start/end date||9/1/15 → 6/30/20|
- National Institute of General Medical Sciences (3R01GM073072-12S1)